Health Canada drug identification number

DIN 02493675 — JORVEZA 1 MG

JORVEZA is a tablet (orally-disintegrating) of Budesonide (Oral) marketed by AVIR PHARMA INC.. The full Budesonide (Oral) monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02493675
Brand name
JORVEZA
Active ingredient
Budesonide (Oral)
Strength
1 MG
Dosage form
TABLET (ORALLY-DISINTEGRATING)
Route
ORAL
Manufacturer
AVIR PHARMA INC.
Health Canada status
MARKETED
Drug class
Locally-acting oral corticosteroid (ileal- or colonic-release glucocorticosteroid)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Budesonide (Oral) products

DINBrandStrengthFormManufacturerStatus
02483874 BUDESONIDE 3 MG CAPSULE (SUSTAINED-RELEASE) TILLOTTS PHARMA GMBH DORMANT
02455889 CORTIMENT 9 MG TABLET (DELAYED- AND EXTENDED-RELEASE) FERRING INC MARKETED
02229293 ENTOCORT 3 MG CAPSULE (SUSTAINED-RELEASE) TILLOTTS PHARMA GMBH MARKETED
02513854 JORVEZA 0.5 MG TABLET (ORALLY-DISINTEGRATING) AVIR PHARMA INC. MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.